One of the challenges in developing effective vaccines for PRRSV is the limited understanding of how neutralizing antibody inhibits PRRSV replication, and how variation in PRRSV leads to escape from neutralizing antibody. In this study, we examined how genetic changes in specific virus proteins leads to increased resistance to neutralizing antibody.